nodes	percent_of_prediction	percent_of_DWPC	metapath
Pravastatin—ABCC2—esophageal cancer	0.282	0.731	CbGaD
Pravastatin—ABCB1—esophageal cancer	0.104	0.269	CbGaD
Pravastatin—SLC16A1—Methotrexate—esophageal cancer	0.0675	0.147	CbGbCtD
Pravastatin—SLCO1B3—Methotrexate—esophageal cancer	0.0377	0.0823	CbGbCtD
Pravastatin—SLC22A11—Methotrexate—esophageal cancer	0.0348	0.0761	CbGbCtD
Pravastatin—ABCC2—Carboplatin—esophageal cancer	0.0348	0.0759	CbGbCtD
Pravastatin—SLC22A7—Methotrexate—esophageal cancer	0.0332	0.0725	CbGbCtD
Pravastatin—ABCG2—Carboplatin—esophageal cancer	0.0314	0.0687	CbGbCtD
Pravastatin—ABCC2—Cisplatin—esophageal cancer	0.0297	0.0649	CbGbCtD
Pravastatin—ABCG2—Cisplatin—esophageal cancer	0.0269	0.0587	CbGbCtD
Pravastatin—SLCO1A2—Methotrexate—esophageal cancer	0.0233	0.0508	CbGbCtD
Pravastatin—SLCO1B1—Methotrexate—esophageal cancer	0.022	0.0479	CbGbCtD
Pravastatin—SLC22A8—Methotrexate—esophageal cancer	0.0203	0.0443	CbGbCtD
Pravastatin—CYP2C9—Capecitabine—esophageal cancer	0.0198	0.0433	CbGbCtD
Pravastatin—ABCC2—Methotrexate—esophageal cancer	0.0193	0.0421	CbGbCtD
Pravastatin—ABCG2—Methotrexate—esophageal cancer	0.0174	0.0381	CbGbCtD
Pravastatin—SLC22A6—Methotrexate—esophageal cancer	0.0141	0.0308	CbGbCtD
Pravastatin—CYP2C9—Cisplatin—esophageal cancer	0.00998	0.0218	CbGbCtD
Pravastatin—ABCB1—Cisplatin—esophageal cancer	0.00969	0.0212	CbGbCtD
Pravastatin—Cardiac pain—Capecitabine—esophageal cancer	0.00645	0.109	CcSEcCtD
Pravastatin—ABCB1—Methotrexate—esophageal cancer	0.00629	0.0137	CbGbCtD
Pravastatin—Memory loss—Cisplatin—esophageal cancer	0.00179	0.0303	CcSEcCtD
Pravastatin—Lung infection—Methotrexate—esophageal cancer	0.00176	0.0298	CcSEcCtD
Pravastatin—Simvastatin—ABCC2—esophageal cancer	0.00133	0.369	CrCbGaD
Pravastatin—Lovastatin—ABCC2—esophageal cancer	0.0013	0.362	CrCbGaD
Pravastatin—Cognitive impairment—Methotrexate—esophageal cancer	0.00111	0.0187	CcSEcCtD
Pravastatin—Nodule—Methotrexate—esophageal cancer	0.000985	0.0166	CcSEcCtD
Pravastatin—VIIth nerve paralysis—Capecitabine—esophageal cancer	0.000947	0.016	CcSEcCtD
Pravastatin—Cognitive disorder—Methotrexate—esophageal cancer	0.000669	0.0113	CcSEcCtD
Pravastatin—HMGCR—neck—esophageal cancer	0.000666	0.0686	CbGeAlD
Pravastatin—Infection—Carboplatin—esophageal cancer	0.000637	0.0108	CcSEcCtD
Pravastatin—Raised liver function tests—Methotrexate—esophageal cancer	0.000627	0.0106	CcSEcCtD
Pravastatin—Loss of libido—Methotrexate—esophageal cancer	0.000627	0.0106	CcSEcCtD
Pravastatin—Tenderness—Cisplatin—esophageal cancer	0.000604	0.0102	CcSEcCtD
Pravastatin—Hearing impaired—Cisplatin—esophageal cancer	0.000554	0.00935	CcSEcCtD
Pravastatin—Pain—Carboplatin—esophageal cancer	0.000548	0.00926	CcSEcCtD
Pravastatin—Hepatocellular injury—Cisplatin—esophageal cancer	0.000527	0.0089	CcSEcCtD
Pravastatin—Body temperature increased—Carboplatin—esophageal cancer	0.000507	0.00856	CcSEcCtD
Pravastatin—Memory impairment—Capecitabine—esophageal cancer	0.000495	0.00836	CcSEcCtD
Pravastatin—Neuropathy—Cisplatin—esophageal cancer	0.000495	0.00836	CcSEcCtD
Pravastatin—ABCB11—digestive system—esophageal cancer	0.000492	0.0507	CbGeAlD
Pravastatin—Simvastatin—ABCB1—esophageal cancer	0.00049	0.136	CrCbGaD
Pravastatin—Lovastatin—ABCB1—esophageal cancer	0.000479	0.133	CrCbGaD
Pravastatin—SLCO1B3—lung—esophageal cancer	0.000477	0.0491	CbGeAlD
Pravastatin—SLC22A11—digestive system—esophageal cancer	0.000455	0.0469	CbGeAlD
Pravastatin—HMGCR—epithelium—esophageal cancer	0.000453	0.0467	CbGeAlD
Pravastatin—HMGCR—bronchus—esophageal cancer	0.000446	0.046	CbGeAlD
Pravastatin—SLC16A1—epithelium—esophageal cancer	0.000446	0.046	CbGeAlD
Pravastatin—SLC22A7—digestive system—esophageal cancer	0.000444	0.0457	CbGeAlD
Pravastatin—HMGCR—smooth muscle tissue—esophageal cancer	0.000437	0.045	CbGeAlD
Pravastatin—Deafness—Cisplatin—esophageal cancer	0.000428	0.00722	CcSEcCtD
Pravastatin—Liver disorder—Methotrexate—esophageal cancer	0.000425	0.00717	CcSEcCtD
Pravastatin—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000424	0.00716	CcSEcCtD
Pravastatin—Nocturia—Capecitabine—esophageal cancer	0.000419	0.00708	CcSEcCtD
Pravastatin—Renal failure acute—Cisplatin—esophageal cancer	0.000415	0.007	CcSEcCtD
Pravastatin—Interstitial lung disease—Methotrexate—esophageal cancer	0.000409	0.0069	CcSEcCtD
Pravastatin—Cataract—Capecitabine—esophageal cancer	0.000408	0.00689	CcSEcCtD
Pravastatin—Hearing impaired—Capecitabine—esophageal cancer	0.000408	0.00689	CcSEcCtD
Pravastatin—Amnesia—Cisplatin—esophageal cancer	0.000407	0.00688	CcSEcCtD
Pravastatin—HMGCR—trachea—esophageal cancer	0.000401	0.0413	CbGeAlD
Pravastatin—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.000389	0.00656	CcSEcCtD
Pravastatin—Neuropathy—Capecitabine—esophageal cancer	0.000365	0.00616	CcSEcCtD
Pravastatin—HMGCR—digestive system—esophageal cancer	0.000345	0.0355	CbGeAlD
Pravastatin—Cramp muscle—Cisplatin—esophageal cancer	0.000345	0.00582	CcSEcCtD
Pravastatin—Nasopharyngitis—Cisplatin—esophageal cancer	0.000342	0.00578	CcSEcCtD
Pravastatin—SLC16A1—digestive system—esophageal cancer	0.00034	0.035	CbGeAlD
Pravastatin—SLCO1B1—digestive system—esophageal cancer	0.00033	0.034	CbGeAlD
Pravastatin—Sleep disorder—Capecitabine—esophageal cancer	0.000326	0.0055	CcSEcCtD
Pravastatin—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000324	0.00548	CcSEcCtD
Pravastatin—Pancreatitis—Cisplatin—esophageal cancer	0.000324	0.00548	CcSEcCtD
Pravastatin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000323	0.00545	CcSEcCtD
Pravastatin—Sweating increased—Cisplatin—esophageal cancer	0.000322	0.00544	CcSEcCtD
Pravastatin—Photosensitivity—Capecitabine—esophageal cancer	0.000321	0.00543	CcSEcCtD
Pravastatin—Deafness—Capecitabine—esophageal cancer	0.000315	0.00533	CcSEcCtD
Pravastatin—Vascular purpura—Capecitabine—esophageal cancer	0.000315	0.00533	CcSEcCtD
Pravastatin—Hepatic failure—Capecitabine—esophageal cancer	0.000314	0.0053	CcSEcCtD
Pravastatin—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000313	0.00528	CcSEcCtD
Pravastatin—Renal failure acute—Capecitabine—esophageal cancer	0.000306	0.00516	CcSEcCtD
Pravastatin—Hot flush—Capecitabine—esophageal cancer	0.000302	0.00509	CcSEcCtD
Pravastatin—Amnesia—Capecitabine—esophageal cancer	0.0003	0.00507	CcSEcCtD
Pravastatin—Menopausal symptoms—Capecitabine—esophageal cancer	0.000299	0.00505	CcSEcCtD
Pravastatin—Vasculitis—Methotrexate—esophageal cancer	0.000296	0.00501	CcSEcCtD
Pravastatin—Purpura—Capecitabine—esophageal cancer	0.000293	0.00494	CcSEcCtD
Pravastatin—SLCO2B1—digestive system—esophageal cancer	0.000292	0.0301	CbGeAlD
Pravastatin—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000291	0.00491	CcSEcCtD
Pravastatin—Arthritis—Capecitabine—esophageal cancer	0.00029	0.0049	CcSEcCtD
Pravastatin—Myocardial infarction—Cisplatin—esophageal cancer	0.000289	0.00488	CcSEcCtD
Pravastatin—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000289	0.00488	CcSEcCtD
Pravastatin—HMGCR—lung—esophageal cancer	0.000288	0.0297	CbGeAlD
Pravastatin—SLC16A1—lung—esophageal cancer	0.000284	0.0292	CbGeAlD
Pravastatin—Diplopia—Capecitabine—esophageal cancer	0.000282	0.00476	CcSEcCtD
Pravastatin—SLCO1A2—digestive system—esophageal cancer	0.000269	0.0277	CbGeAlD
Pravastatin—Mood swings—Capecitabine—esophageal cancer	0.000267	0.00451	CcSEcCtD
Pravastatin—Liver function test abnormal—Capecitabine—esophageal cancer	0.000261	0.0044	CcSEcCtD
Pravastatin—Gynaecomastia—Methotrexate—esophageal cancer	0.000259	0.00437	CcSEcCtD
Pravastatin—Dry skin—Capecitabine—esophageal cancer	0.000259	0.00437	CcSEcCtD
Pravastatin—Visual impairment—Cisplatin—esophageal cancer	0.000255	0.00431	CcSEcCtD
Pravastatin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000254	0.00429	CcSEcCtD
Pravastatin—Nasopharyngitis—Capecitabine—esophageal cancer	0.000252	0.00426	CcSEcCtD
Pravastatin—ABCC2—digestive system—esophageal cancer	0.00025	0.0258	CbGeAlD
Pravastatin—Muscular weakness—Capecitabine—esophageal cancer	0.000249	0.0042	CcSEcCtD
Pravastatin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000249	0.0042	CcSEcCtD
Pravastatin—Tinnitus—Cisplatin—esophageal cancer	0.000247	0.00417	CcSEcCtD
Pravastatin—Flushing—Cisplatin—esophageal cancer	0.000246	0.00415	CcSEcCtD
Pravastatin—Cardiac disorder—Cisplatin—esophageal cancer	0.000246	0.00415	CcSEcCtD
Pravastatin—Abdominal distension—Capecitabine—esophageal cancer	0.000246	0.00415	CcSEcCtD
Pravastatin—SLCO2B1—lung—esophageal cancer	0.000244	0.0251	CbGeAlD
Pravastatin—Influenza—Capecitabine—esophageal cancer	0.000244	0.00412	CcSEcCtD
Pravastatin—Photosensitivity—Methotrexate—esophageal cancer	0.000239	0.00404	CcSEcCtD
Pravastatin—Sweating increased—Capecitabine—esophageal cancer	0.000238	0.00401	CcSEcCtD
Pravastatin—Angina pectoris—Capecitabine—esophageal cancer	0.000238	0.00401	CcSEcCtD
Pravastatin—Arrhythmia—Cisplatin—esophageal cancer	0.000237	0.00399	CcSEcCtD
Pravastatin—Alopecia—Cisplatin—esophageal cancer	0.000234	0.00395	CcSEcCtD
Pravastatin—Hepatic failure—Methotrexate—esophageal cancer	0.000234	0.00395	CcSEcCtD
Pravastatin—Dysuria—Capecitabine—esophageal cancer	0.000228	0.00385	CcSEcCtD
Pravastatin—Renal failure acute—Methotrexate—esophageal cancer	0.000228	0.00384	CcSEcCtD
Pravastatin—Flatulence—Cisplatin—esophageal cancer	0.000227	0.00384	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000227	0.00383	CcSEcCtD
Pravastatin—SLCO1A2—lung—esophageal cancer	0.000224	0.0231	CbGeAlD
Pravastatin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000223	0.00376	CcSEcCtD
Pravastatin—Weight increased—Capecitabine—esophageal cancer	0.000222	0.00375	CcSEcCtD
Pravastatin—Muscle spasms—Cisplatin—esophageal cancer	0.000222	0.00374	CcSEcCtD
Pravastatin—Weight decreased—Capecitabine—esophageal cancer	0.000221	0.00373	CcSEcCtD
Pravastatin—Vision blurred—Cisplatin—esophageal cancer	0.000217	0.00367	CcSEcCtD
Pravastatin—Depression—Capecitabine—esophageal cancer	0.000217	0.00366	CcSEcCtD
Pravastatin—Tremor—Cisplatin—esophageal cancer	0.000216	0.00365	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000216	0.00364	CcSEcCtD
Pravastatin—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000214	0.00362	CcSEcCtD
Pravastatin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000214	0.00361	CcSEcCtD
Pravastatin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000213	0.0036	CcSEcCtD
Pravastatin—Myocardial infarction—Capecitabine—esophageal cancer	0.000213	0.0036	CcSEcCtD
Pravastatin—Anaemia—Cisplatin—esophageal cancer	0.000213	0.0036	CcSEcCtD
Pravastatin—Jaundice—Capecitabine—esophageal cancer	0.000212	0.00358	CcSEcCtD
Pravastatin—Urinary tract infection—Capecitabine—esophageal cancer	0.000211	0.00357	CcSEcCtD
Pravastatin—Malaise—Cisplatin—esophageal cancer	0.000208	0.00351	CcSEcCtD
Pravastatin—Leukopenia—Cisplatin—esophageal cancer	0.000206	0.00348	CcSEcCtD
Pravastatin—Mood swings—Methotrexate—esophageal cancer	0.000199	0.00336	CcSEcCtD
Pravastatin—HMGCR—lymph node—esophageal cancer	0.000197	0.0203	CbGeAlD
Pravastatin—Myalgia—Cisplatin—esophageal cancer	0.000196	0.00331	CcSEcCtD
Pravastatin—Rhinitis—Capecitabine—esophageal cancer	0.000196	0.0033	CcSEcCtD
Pravastatin—Anxiety—Cisplatin—esophageal cancer	0.000196	0.0033	CcSEcCtD
Pravastatin—Hepatitis—Capecitabine—esophageal cancer	0.000195	0.0033	CcSEcCtD
Pravastatin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000194	0.00328	CcSEcCtD
Pravastatin—SLC16A1—lymph node—esophageal cancer	0.000194	0.02	CbGeAlD
Pravastatin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000194	0.00327	CcSEcCtD
Pravastatin—Discomfort—Cisplatin—esophageal cancer	0.000194	0.00327	CcSEcCtD
Pravastatin—Pharyngitis—Capecitabine—esophageal cancer	0.000194	0.00327	CcSEcCtD
Pravastatin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000189	0.00319	CcSEcCtD
Pravastatin—Oedema—Cisplatin—esophageal cancer	0.000188	0.00318	CcSEcCtD
Pravastatin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000188	0.00318	CcSEcCtD
Pravastatin—Visual impairment—Capecitabine—esophageal cancer	0.000188	0.00318	CcSEcCtD
Pravastatin—Infection—Cisplatin—esophageal cancer	0.000187	0.00316	CcSEcCtD
Pravastatin—Erythema multiforme—Capecitabine—esophageal cancer	0.000185	0.00312	CcSEcCtD
Pravastatin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000184	0.00311	CcSEcCtD
Pravastatin—Tinnitus—Capecitabine—esophageal cancer	0.000182	0.00307	CcSEcCtD
Pravastatin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000182	0.00307	CcSEcCtD
Pravastatin—Cardiac disorder—Capecitabine—esophageal cancer	0.000181	0.00306	CcSEcCtD
Pravastatin—Flushing—Capecitabine—esophageal cancer	0.000181	0.00306	CcSEcCtD
Pravastatin—Eosinophilia—Methotrexate—esophageal cancer	0.00018	0.00304	CcSEcCtD
Pravastatin—Anorexia—Cisplatin—esophageal cancer	0.000179	0.00303	CcSEcCtD
Pravastatin—Pancreatitis—Methotrexate—esophageal cancer	0.000178	0.00301	CcSEcCtD
Pravastatin—Chills—Capecitabine—esophageal cancer	0.000175	0.00296	CcSEcCtD
Pravastatin—Arrhythmia—Capecitabine—esophageal cancer	0.000174	0.00294	CcSEcCtD
Pravastatin—Alopecia—Capecitabine—esophageal cancer	0.000172	0.00291	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000171	0.00289	CcSEcCtD
Pravastatin—Dysuria—Methotrexate—esophageal cancer	0.00017	0.00287	CcSEcCtD
Pravastatin—CYP3A5—digestive system—esophageal cancer	0.00017	0.0175	CbGeAlD
Pravastatin—Paraesthesia—Cisplatin—esophageal cancer	0.000169	0.00285	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000169	0.00285	CcSEcCtD
Pravastatin—Dyspnoea—Cisplatin—esophageal cancer	0.000168	0.00283	CcSEcCtD
Pravastatin—Flatulence—Capecitabine—esophageal cancer	0.000167	0.00283	CcSEcCtD
Pravastatin—Erectile dysfunction—Methotrexate—esophageal cancer	0.000167	0.00282	CcSEcCtD
Pravastatin—SLCO2B1—lymph node—esophageal cancer	0.000167	0.0172	CbGeAlD
Pravastatin—CYP2C9—digestive system—esophageal cancer	0.000167	0.0172	CbGeAlD
Pravastatin—Dysgeusia—Capecitabine—esophageal cancer	0.000166	0.00281	CcSEcCtD
Pravastatin—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000166	0.0028	CcSEcCtD
Pravastatin—Decreased appetite—Cisplatin—esophageal cancer	0.000164	0.00276	CcSEcCtD
Pravastatin—Muscle spasms—Capecitabine—esophageal cancer	0.000163	0.00276	CcSEcCtD
Pravastatin—Depression—Methotrexate—esophageal cancer	0.000161	0.00273	CcSEcCtD
Pravastatin—Pain—Cisplatin—esophageal cancer	0.000161	0.00272	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00016	0.00271	CcSEcCtD
Pravastatin—Vision blurred—Capecitabine—esophageal cancer	0.00016	0.0027	CcSEcCtD
Pravastatin—Tremor—Capecitabine—esophageal cancer	0.000159	0.00269	CcSEcCtD
Pravastatin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000158	0.00266	CcSEcCtD
Pravastatin—Anaemia—Capecitabine—esophageal cancer	0.000157	0.00265	CcSEcCtD
Pravastatin—Feeling abnormal—Cisplatin—esophageal cancer	0.000155	0.00262	CcSEcCtD
Pravastatin—Malaise—Capecitabine—esophageal cancer	0.000153	0.00259	CcSEcCtD
Pravastatin—Vertigo—Capecitabine—esophageal cancer	0.000153	0.00258	CcSEcCtD
Pravastatin—ABCG2—lung—esophageal cancer	0.000153	0.0157	CbGeAlD
Pravastatin—Leukopenia—Capecitabine—esophageal cancer	0.000152	0.00257	CcSEcCtD
Pravastatin—Body temperature increased—Cisplatin—esophageal cancer	0.000149	0.00251	CcSEcCtD
Pravastatin—Cough—Capecitabine—esophageal cancer	0.000148	0.0025	CcSEcCtD
Pravastatin—Hypertension—Capecitabine—esophageal cancer	0.000147	0.00248	CcSEcCtD
Pravastatin—Hepatitis—Methotrexate—esophageal cancer	0.000145	0.00245	CcSEcCtD
Pravastatin—Myalgia—Capecitabine—esophageal cancer	0.000145	0.00244	CcSEcCtD
Pravastatin—Arthralgia—Capecitabine—esophageal cancer	0.000145	0.00244	CcSEcCtD
Pravastatin—Chest pain—Capecitabine—esophageal cancer	0.000145	0.00244	CcSEcCtD
Pravastatin—Pharyngitis—Methotrexate—esophageal cancer	0.000144	0.00244	CcSEcCtD
Pravastatin—Anxiety—Capecitabine—esophageal cancer	0.000144	0.00243	CcSEcCtD
Pravastatin—ABCC2—lymph node—esophageal cancer	0.000143	0.0147	CbGeAlD
Pravastatin—Discomfort—Capecitabine—esophageal cancer	0.000143	0.00241	CcSEcCtD
Pravastatin—CYP3A5—lung—esophageal cancer	0.000142	0.0146	CbGeAlD
Pravastatin—Visual impairment—Methotrexate—esophageal cancer	0.00014	0.00236	CcSEcCtD
Pravastatin—Confusional state—Capecitabine—esophageal cancer	0.00014	0.00236	CcSEcCtD
Pravastatin—Oedema—Capecitabine—esophageal cancer	0.000139	0.00234	CcSEcCtD
Pravastatin—Hypersensitivity—Cisplatin—esophageal cancer	0.000139	0.00234	CcSEcCtD
Pravastatin—Infection—Capecitabine—esophageal cancer	0.000138	0.00233	CcSEcCtD
Pravastatin—Erythema multiforme—Methotrexate—esophageal cancer	0.000137	0.00232	CcSEcCtD
Pravastatin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000136	0.00229	CcSEcCtD
Pravastatin—Tinnitus—Methotrexate—esophageal cancer	0.000135	0.00229	CcSEcCtD
Pravastatin—Asthenia—Cisplatin—esophageal cancer	0.000135	0.00228	CcSEcCtD
Pravastatin—Cardiac disorder—Methotrexate—esophageal cancer	0.000135	0.00228	CcSEcCtD
Pravastatin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000134	0.00226	CcSEcCtD
Pravastatin—Anorexia—Capecitabine—esophageal cancer	0.000132	0.00223	CcSEcCtD
Pravastatin—Chills—Methotrexate—esophageal cancer	0.00013	0.0022	CcSEcCtD
Pravastatin—Diarrhoea—Cisplatin—esophageal cancer	0.000129	0.00217	CcSEcCtD
Pravastatin—Alopecia—Methotrexate—esophageal cancer	0.000128	0.00217	CcSEcCtD
Pravastatin—CYP3A4—digestive system—esophageal cancer	0.000127	0.0131	CbGeAlD
Pravastatin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000126	0.00213	CcSEcCtD
Pravastatin—Insomnia—Capecitabine—esophageal cancer	0.000125	0.00212	CcSEcCtD
Pravastatin—CYP2D6—digestive system—esophageal cancer	0.000125	0.0129	CbGeAlD
Pravastatin—Paraesthesia—Capecitabine—esophageal cancer	0.000125	0.0021	CcSEcCtD
Pravastatin—Dysgeusia—Methotrexate—esophageal cancer	0.000124	0.00209	CcSEcCtD
Pravastatin—Dyspnoea—Capecitabine—esophageal cancer	0.000124	0.00209	CcSEcCtD
Pravastatin—Dyspepsia—Capecitabine—esophageal cancer	0.000122	0.00206	CcSEcCtD
Pravastatin—Decreased appetite—Capecitabine—esophageal cancer	0.000121	0.00204	CcSEcCtD
Pravastatin—Vomiting—Cisplatin—esophageal cancer	0.00012	0.00202	CcSEcCtD
Pravastatin—Fatigue—Capecitabine—esophageal cancer	0.00012	0.00202	CcSEcCtD
Pravastatin—Vision blurred—Methotrexate—esophageal cancer	0.000119	0.00201	CcSEcCtD
Pravastatin—Rash—Cisplatin—esophageal cancer	0.000119	0.002	CcSEcCtD
Pravastatin—Constipation—Capecitabine—esophageal cancer	0.000119	0.002	CcSEcCtD
Pravastatin—Pain—Capecitabine—esophageal cancer	0.000119	0.002	CcSEcCtD
Pravastatin—Dermatitis—Cisplatin—esophageal cancer	0.000119	0.002	CcSEcCtD
Pravastatin—ABCB1—epithelium—esophageal cancer	0.000118	0.0122	CbGeAlD
Pravastatin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000117	0.00198	CcSEcCtD
Pravastatin—Anaemia—Methotrexate—esophageal cancer	0.000117	0.00197	CcSEcCtD
Pravastatin—Feeling abnormal—Capecitabine—esophageal cancer	0.000114	0.00193	CcSEcCtD
Pravastatin—Malaise—Methotrexate—esophageal cancer	0.000114	0.00193	CcSEcCtD
Pravastatin—Vertigo—Methotrexate—esophageal cancer	0.000114	0.00192	CcSEcCtD
Pravastatin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000113	0.00191	CcSEcCtD
Pravastatin—Leukopenia—Methotrexate—esophageal cancer	0.000113	0.00191	CcSEcCtD
Pravastatin—Nausea—Cisplatin—esophageal cancer	0.000112	0.00189	CcSEcCtD
Pravastatin—Cough—Methotrexate—esophageal cancer	0.00011	0.00186	CcSEcCtD
Pravastatin—Urticaria—Capecitabine—esophageal cancer	0.00011	0.00186	CcSEcCtD
Pravastatin—Abdominal pain—Capecitabine—esophageal cancer	0.00011	0.00185	CcSEcCtD
Pravastatin—Body temperature increased—Capecitabine—esophageal cancer	0.00011	0.00185	CcSEcCtD
Pravastatin—Chest pain—Methotrexate—esophageal cancer	0.000108	0.00182	CcSEcCtD
Pravastatin—Arthralgia—Methotrexate—esophageal cancer	0.000108	0.00182	CcSEcCtD
Pravastatin—Myalgia—Methotrexate—esophageal cancer	0.000108	0.00182	CcSEcCtD
Pravastatin—Discomfort—Methotrexate—esophageal cancer	0.000106	0.0018	CcSEcCtD
Pravastatin—ABCB1—trachea—esophageal cancer	0.000105	0.0108	CbGeAlD
Pravastatin—ABCG2—lymph node—esophageal cancer	0.000104	0.0107	CbGeAlD
Pravastatin—Confusional state—Methotrexate—esophageal cancer	0.000104	0.00176	CcSEcCtD
Pravastatin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000103	0.00174	CcSEcCtD
Pravastatin—Infection—Methotrexate—esophageal cancer	0.000103	0.00173	CcSEcCtD
Pravastatin—Hypersensitivity—Capecitabine—esophageal cancer	0.000102	0.00173	CcSEcCtD
Pravastatin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000101	0.00171	CcSEcCtD
Pravastatin—Hyperhidrosis—Methotrexate—esophageal cancer	9.98e-05	0.00169	CcSEcCtD
Pravastatin—Asthenia—Capecitabine—esophageal cancer	9.95e-05	0.00168	CcSEcCtD
Pravastatin—Anorexia—Methotrexate—esophageal cancer	9.84e-05	0.00166	CcSEcCtD
Pravastatin—Pruritus—Capecitabine—esophageal cancer	9.81e-05	0.00166	CcSEcCtD
Pravastatin—Diarrhoea—Capecitabine—esophageal cancer	9.49e-05	0.0016	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	9.41e-05	0.00159	CcSEcCtD
Pravastatin—Insomnia—Methotrexate—esophageal cancer	9.34e-05	0.00158	CcSEcCtD
Pravastatin—Paraesthesia—Methotrexate—esophageal cancer	9.27e-05	0.00157	CcSEcCtD
Pravastatin—Dyspnoea—Methotrexate—esophageal cancer	9.2e-05	0.00155	CcSEcCtD
Pravastatin—Dizziness—Capecitabine—esophageal cancer	9.17e-05	0.00155	CcSEcCtD
Pravastatin—Dyspepsia—Methotrexate—esophageal cancer	9.09e-05	0.00153	CcSEcCtD
Pravastatin—ABCB1—digestive system—esophageal cancer	9e-05	0.00927	CbGeAlD
Pravastatin—Decreased appetite—Methotrexate—esophageal cancer	8.97e-05	0.00152	CcSEcCtD
Pravastatin—Fatigue—Methotrexate—esophageal cancer	8.9e-05	0.0015	CcSEcCtD
Pravastatin—Pain—Methotrexate—esophageal cancer	8.83e-05	0.00149	CcSEcCtD
Pravastatin—Vomiting—Capecitabine—esophageal cancer	8.82e-05	0.00149	CcSEcCtD
Pravastatin—Rash—Capecitabine—esophageal cancer	8.74e-05	0.00148	CcSEcCtD
Pravastatin—Dermatitis—Capecitabine—esophageal cancer	8.74e-05	0.00148	CcSEcCtD
Pravastatin—Headache—Capecitabine—esophageal cancer	8.69e-05	0.00147	CcSEcCtD
Pravastatin—Feeling abnormal—Methotrexate—esophageal cancer	8.51e-05	0.00144	CcSEcCtD
Pravastatin—Gastrointestinal pain—Methotrexate—esophageal cancer	8.44e-05	0.00143	CcSEcCtD
Pravastatin—Nausea—Capecitabine—esophageal cancer	8.24e-05	0.00139	CcSEcCtD
Pravastatin—Urticaria—Methotrexate—esophageal cancer	8.2e-05	0.00138	CcSEcCtD
Pravastatin—Body temperature increased—Methotrexate—esophageal cancer	8.16e-05	0.00138	CcSEcCtD
Pravastatin—Abdominal pain—Methotrexate—esophageal cancer	8.16e-05	0.00138	CcSEcCtD
Pravastatin—Hypersensitivity—Methotrexate—esophageal cancer	7.61e-05	0.00128	CcSEcCtD
Pravastatin—ABCB1—lung—esophageal cancer	7.52e-05	0.00775	CbGeAlD
Pravastatin—Asthenia—Methotrexate—esophageal cancer	7.41e-05	0.00125	CcSEcCtD
Pravastatin—Pruritus—Methotrexate—esophageal cancer	7.3e-05	0.00123	CcSEcCtD
Pravastatin—Diarrhoea—Methotrexate—esophageal cancer	7.06e-05	0.00119	CcSEcCtD
Pravastatin—Dizziness—Methotrexate—esophageal cancer	6.83e-05	0.00115	CcSEcCtD
Pravastatin—Vomiting—Methotrexate—esophageal cancer	6.56e-05	0.00111	CcSEcCtD
Pravastatin—Rash—Methotrexate—esophageal cancer	6.51e-05	0.0011	CcSEcCtD
Pravastatin—Dermatitis—Methotrexate—esophageal cancer	6.5e-05	0.0011	CcSEcCtD
Pravastatin—Headache—Methotrexate—esophageal cancer	6.47e-05	0.00109	CcSEcCtD
Pravastatin—Nausea—Methotrexate—esophageal cancer	6.13e-05	0.00104	CcSEcCtD
Pravastatin—ABCB1—lymph node—esophageal cancer	5.14e-05	0.0053	CbGeAlD
Pravastatin—SLC16A1—Hemostasis—PIK3CA—esophageal cancer	1.23e-05	0.000146	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CYP26A1—esophageal cancer	1.23e-05	0.000146	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—ABCB1—esophageal cancer	1.22e-05	0.000146	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CA2—esophageal cancer	1.22e-05	0.000145	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CYP2A6—esophageal cancer	1.22e-05	0.000145	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ALOX15—esophageal cancer	1.19e-05	0.000142	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—TP53—esophageal cancer	1.19e-05	0.000142	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	1.17e-05	0.000139	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	1.16e-05	0.000139	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PTGS1—esophageal cancer	1.16e-05	0.000138	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—ENO1—esophageal cancer	1.16e-05	0.000138	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.15e-05	0.000138	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CA2—esophageal cancer	1.15e-05	0.000137	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ADH1B—esophageal cancer	1.14e-05	0.000136	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CA2—esophageal cancer	1.14e-05	0.000136	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—TPI1—esophageal cancer	1.14e-05	0.000136	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GSTO1—esophageal cancer	1.14e-05	0.000136	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PSME2—esophageal cancer	1.14e-05	0.000136	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PSME1—esophageal cancer	1.14e-05	0.000136	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ADH7—esophageal cancer	1.13e-05	0.000135	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PLCE1—esophageal cancer	1.13e-05	0.000135	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—CREBBP—esophageal cancer	1.13e-05	0.000135	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.12e-05	0.000134	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.11e-05	0.000133	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ALDOB—esophageal cancer	1.09e-05	0.00013	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—TYMP—esophageal cancer	1.09e-05	0.00013	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.07e-05	0.000128	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.07e-05	0.000128	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ADH7—esophageal cancer	1.07e-05	0.000127	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PLCE1—esophageal cancer	1.07e-05	0.000127	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—HMOX1—esophageal cancer	1.06e-05	0.000127	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.06e-05	0.000126	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	1.06e-05	0.000126	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ADH7—esophageal cancer	1.06e-05	0.000126	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.06e-05	0.000126	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GAPDH—esophageal cancer	1.05e-05	0.000125	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.05e-05	0.000125	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.04e-05	0.000124	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CRABP1—esophageal cancer	1.04e-05	0.000124	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.03e-05	0.000123	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—ABCB1—esophageal cancer	1.02e-05	0.000122	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—NOS3—esophageal cancer	1.01e-05	0.000121	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	9.97e-06	0.000119	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ADH1B—esophageal cancer	9.95e-06	0.000118	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GNG7—esophageal cancer	9.91e-06	0.000118	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—CREBBP—esophageal cancer	9.89e-06	0.000118	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—TPI1—esophageal cancer	9.87e-06	0.000118	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GSTO1—esophageal cancer	9.87e-06	0.000118	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.83e-06	0.000117	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CYP1B1—esophageal cancer	9.82e-06	0.000117	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	9.73e-06	0.000116	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—BLVRB—esophageal cancer	9.67e-06	0.000115	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	9.67e-06	0.000115	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—TYMP—esophageal cancer	9.5e-06	0.000113	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ALDOB—esophageal cancer	9.46e-06	0.000113	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ADH1B—esophageal cancer	9.37e-06	0.000112	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	9.33e-06	0.000111	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ADH1B—esophageal cancer	9.29e-06	0.000111	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ALDH2—esophageal cancer	9.29e-06	0.000111	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PTGS2—esophageal cancer	9.26e-06	0.00011	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.25e-06	0.00011	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CYP26A1—esophageal cancer	9.25e-06	0.00011	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CYP19A1—esophageal cancer	9.23e-06	0.00011	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	9.12e-06	0.000109	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GAPDH—esophageal cancer	9.11e-06	0.000108	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—HMOX1—esophageal cancer	9.1e-06	0.000108	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CRABP1—esophageal cancer	9.02e-06	0.000108	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ALOX15—esophageal cancer	9.01e-06	0.000107	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—TYMP—esophageal cancer	8.96e-06	0.000107	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.93e-06	0.000106	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—TYMP—esophageal cancer	8.88e-06	0.000106	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—NOS3—esophageal cancer	8.85e-06	0.000105	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GSTT1—esophageal cancer	8.83e-06	0.000105	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—ABCB1—esophageal cancer	8.74e-06	0.000104	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CYP2A6—esophageal cancer	8.73e-06	0.000104	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CYP26A1—esophageal cancer	8.71e-06	0.000104	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—CREBBP—esophageal cancer	8.69e-06	0.000104	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CYP26A1—esophageal cancer	8.64e-06	0.000103	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GSTO1—esophageal cancer	8.6e-06	0.000102	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—TPI1—esophageal cancer	8.6e-06	0.000102	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GNG7—esophageal cancer	8.58e-06	0.000102	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ALOX15—esophageal cancer	8.49e-06	0.000101	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—HMOX1—esophageal cancer	8.43e-06	0.0001	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ALOX15—esophageal cancer	8.42e-06	0.0001	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PTGS1—esophageal cancer	8.28e-06	9.86e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ENO1—esophageal cancer	8.28e-06	9.86e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ALDOB—esophageal cancer	8.24e-06	9.82e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	8.22e-06	9.79e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CA1—esophageal cancer	8.22e-06	9.79e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—CREBBP—esophageal cancer	8.18e-06	9.74e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PSME2—esophageal cancer	8.16e-06	9.72e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PSME1—esophageal cancer	8.16e-06	9.72e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—TPI1—esophageal cancer	8.1e-06	9.65e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GSTO1—esophageal cancer	8.1e-06	9.65e-05	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PTGS2—esophageal cancer	8.1e-06	9.65e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—ABCB1—esophageal cancer	8.09e-06	9.64e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ALDH2—esophageal cancer	8.04e-06	9.58e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GSTO1—esophageal cancer	8.03e-06	9.57e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—TPI1—esophageal cancer	8.03e-06	9.57e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GAPDH—esophageal cancer	7.93e-06	9.45e-05	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	7.92e-06	9.43e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CRABP1—esophageal cancer	7.86e-06	9.37e-05	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—NOS3—esophageal cancer	7.78e-06	9.27e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ALDOB—esophageal cancer	7.77e-06	9.25e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.72e-06	9.2e-05	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—EP300—esophageal cancer	7.7e-06	9.18e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ALDOB—esophageal cancer	7.7e-06	9.17e-05	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	7.66e-06	9.13e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GSTT1—esophageal cancer	7.65e-06	9.11e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CYP2A6—esophageal cancer	7.56e-06	9.01e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.53e-06	8.97e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CA2—esophageal cancer	7.52e-06	8.95e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GNG7—esophageal cancer	7.48e-06	8.91e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GAPDH—esophageal cancer	7.48e-06	8.91e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GAPDH—esophageal cancer	7.41e-06	8.83e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CRABP1—esophageal cancer	7.41e-06	8.83e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CRABP1—esophageal cancer	7.34e-06	8.75e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—NOS3—esophageal cancer	7.32e-06	8.72e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PTGS1—esophageal cancer	7.17e-06	8.54e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ENO1—esophageal cancer	7.17e-06	8.54e-05	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PTGS2—esophageal cancer	7.12e-06	8.48e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PSME2—esophageal cancer	7.06e-06	8.42e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PSME1—esophageal cancer	7.06e-06	8.42e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GNG7—esophageal cancer	7.05e-06	8.4e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CYP1B1—esophageal cancer	7.04e-06	8.38e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ALDH2—esophageal cancer	7.01e-06	8.35e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ADH7—esophageal cancer	6.99e-06	8.33e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PLCE1—esophageal cancer	6.99e-06	8.33e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GNG7—esophageal cancer	6.99e-06	8.32e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—CREBBP—esophageal cancer	6.83e-06	8.13e-05	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—EP300—esophageal cancer	6.73e-06	8.02e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PTGS2—esophageal cancer	6.7e-06	7.98e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GSTT1—esophageal cancer	6.67e-06	7.94e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CYP19A1—esophageal cancer	6.62e-06	7.88e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.6e-06	7.87e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ALDH2—esophageal cancer	6.6e-06	7.87e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CYP2A6—esophageal cancer	6.59e-06	7.85e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ALDH2—esophageal cancer	6.55e-06	7.8e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GSTT1—esophageal cancer	6.28e-06	7.48e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ENO1—esophageal cancer	6.25e-06	7.44e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PTGS1—esophageal cancer	6.25e-06	7.44e-05	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.24e-06	7.43e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GSTT1—esophageal cancer	6.23e-06	7.42e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CYP2A6—esophageal cancer	6.21e-06	7.4e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.17e-06	7.35e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CYP2A6—esophageal cancer	6.15e-06	7.33e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PSME1—esophageal cancer	6.15e-06	7.33e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PSME2—esophageal cancer	6.15e-06	7.33e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.13e-06	7.3e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.13e-06	7.3e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—NOS3—esophageal cancer	6.11e-06	7.28e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CYP1B1—esophageal cancer	6.1e-06	7.26e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—HMOX1—esophageal cancer	6.04e-06	7.19e-05	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—EP300—esophageal cancer	5.92e-06	7.05e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PTGS1—esophageal cancer	5.89e-06	7.01e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ENO1—esophageal cancer	5.89e-06	7.01e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—TYMP—esophageal cancer	5.86e-06	6.98e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—CREBBP—esophageal cancer	5.84e-06	6.96e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PTGS1—esophageal cancer	5.83e-06	6.95e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ENO1—esophageal cancer	5.83e-06	6.95e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PSME2—esophageal cancer	5.8e-06	6.91e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PSME1—esophageal cancer	5.8e-06	6.91e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ABCB1—esophageal cancer	5.8e-06	6.9e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PSME1—esophageal cancer	5.75e-06	6.85e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PSME2—esophageal cancer	5.75e-06	6.85e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CYP19A1—esophageal cancer	5.73e-06	6.83e-05	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PIK3CA—esophageal cancer	5.7e-06	6.79e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	5.7e-06	6.79e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PTGS2—esophageal cancer	5.59e-06	6.66e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—EP300—esophageal cancer	5.57e-06	6.64e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ALOX15—esophageal cancer	5.55e-06	6.61e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CREBBP—esophageal cancer	5.41e-06	6.44e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CYP1B1—esophageal cancer	5.31e-06	6.33e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—TPI1—esophageal cancer	5.3e-06	6.31e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.3e-06	6.31e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—HMOX1—esophageal cancer	5.23e-06	6.23e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—NOS3—esophageal cancer	5.23e-06	6.23e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.13e-06	6.11e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.08e-06	6.05e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.02e-06	5.98e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ABCB1—esophageal cancer	5.02e-06	5.98e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CYP1B1—esophageal cancer	5e-06	5.96e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CYP19A1—esophageal cancer	4.99e-06	5.95e-05	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PIK3CA—esophageal cancer	4.98e-06	5.93e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CYP1B1—esophageal cancer	4.96e-06	5.91e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GAPDH—esophageal cancer	4.89e-06	5.82e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.84e-06	5.77e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—NOS3—esophageal cancer	4.84e-06	5.77e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PTGS2—esophageal cancer	4.78e-06	5.7e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CYP19A1—esophageal cancer	4.71e-06	5.61e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CYP19A1—esophageal cancer	4.66e-06	5.56e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—EP300—esophageal cancer	4.65e-06	5.54e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GNG7—esophageal cancer	4.61e-06	5.49e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—HMOX1—esophageal cancer	4.56e-06	5.43e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PTGS2—esophageal cancer	4.43e-06	5.27e-05	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PIK3CA—esophageal cancer	4.38e-06	5.22e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.32e-06	5.14e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—HMOX1—esophageal cancer	4.29e-06	5.11e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—HMOX1—esophageal cancer	4.26e-06	5.07e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.18e-06	4.97e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ABCB1—esophageal cancer	4.12e-06	4.91e-05	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PIK3CA—esophageal cancer	4.12e-06	4.91e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.11e-06	4.89e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ABCB1—esophageal cancer	4.09e-06	4.87e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.06e-06	4.84e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—EP300—esophageal cancer	3.98e-06	4.74e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CREBBP—esophageal cancer	3.87e-06	4.61e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.85e-06	4.58e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ENO1—esophageal cancer	3.85e-06	4.58e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.8e-06	4.52e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PSME1—esophageal cancer	3.79e-06	4.52e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PSME2—esophageal cancer	3.79e-06	4.52e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—EP300—esophageal cancer	3.68e-06	4.39e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—NOS3—esophageal cancer	3.47e-06	4.13e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	3.44e-06	4.1e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CREBBP—esophageal cancer	3.35e-06	4e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.27e-06	3.9e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PTGS2—esophageal cancer	3.17e-06	3.78e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.09e-06	3.68e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.08e-06	3.66e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—NOS3—esophageal cancer	3e-06	3.58e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	2.94e-06	3.5e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CREBBP—esophageal cancer	2.92e-06	3.48e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.81e-06	3.34e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.75e-06	3.28e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PTGS2—esophageal cancer	2.75e-06	3.27e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CREBBP—esophageal cancer	2.73e-06	3.25e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PIK3CA—esophageal cancer	2.72e-06	3.24e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.69e-06	3.21e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—EP300—esophageal cancer	2.64e-06	3.14e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NOS3—esophageal cancer	2.62e-06	3.12e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NOS3—esophageal cancer	2.47e-06	2.94e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NOS3—esophageal cancer	2.44e-06	2.91e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PTGS2—esophageal cancer	2.39e-06	2.85e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—EP300—esophageal cancer	2.28e-06	2.72e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.26e-06	2.69e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.24e-06	2.66e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—EP300—esophageal cancer	1.99e-06	2.37e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1.95e-06	2.32e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—EP300—esophageal cancer	1.88e-06	2.23e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—EP300—esophageal cancer	1.86e-06	2.22e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.8e-06	2.15e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.69e-06	2.01e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NOS3—esophageal cancer	1.61e-06	1.92e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.47e-06	1.76e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.47e-06	1.75e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.38e-06	1.64e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—EP300—esophageal cancer	1.23e-06	1.46e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.07e-07	1.08e-05	CbGpPWpGaD
